Administration of synergistic amounts of modified citrus pectin and honokiol to treat inflammation and anti-oxidant needs
AssigneeEconugenics, Inc.
InventorIsaac Eliaz
Life of this patent
Estimating the term…
Abstract
A method of inhibiting or reducing inflammation in a mammal comprises administering MCP or similar Gal-3 binding moiety with honokiol in a range of about 8-10:1, by weight, MCP to honokiol. By pursuing complimentary pathways, a synergistic combination is achieved, where the reduction or degree of inflammation inhibition is greater than would be expected by the added administration of these two agents. The inflammation may be manifested as gingivitis, which may be addressed by a preparation comprising honokiol and MCP, or an MCP equivalent, in the indicated range by weight, where they are in the form of an oral rinse, lozenge, sucking candy, toothpaste or tablet.
Claims8
A method of treating a mammal, comprising:
- a) Selecting a mammal in need of inhibition or reduction of inflammation;
- and
- b) Administering to said mammal selected a combination of honokiol and modified citrus pectin (MCP) in amounts which exhibit synergy in the reduction or inhibition of inflammation, said administration being continued for a period of time sufficient to achieve the needed inhibition or reduction of inflammation in said mammal.
Dependencies are inferred from the claim text.